• Opinion
• [Reporter’s View] KRPIA pulls out ‘structural reform' card
• by Eo, Yun-Ho Oct 12, 2023 05:37am

• Opinion
• [Reporter's view] Paid-in capital increase & bio ventures
• by Lee, Seok-Jun Sep 26, 2023 05:49am

• Opinion
• [Reporter’s View] Biobetters to prosper with better prices
• by Eo, Yun-Ho Sep 21, 2023 05:23am

• Opinion
• [Reporter’s View] Industry suffers from ‘Re-eval Neurosis'
• by Kim, Jin-Gu Sep 20, 2023 05:36am

• Opinion
• [Reporter’s View] MFDS makes changes ahead PIC/S reeval
• by Lee, Hye-Kyung Sep 13, 2023 05:28am

• Opinion
• [Reporter's view] What is the solution
• by Eo, Yun-Ho Sep 13, 2023 05:28am

• Opinion
• [Reporter's view] Obesity-themed stocks
• by Lee, Seok-Jun Sep 11, 2023 05:29am

• Opinion
• [Reporter's view] Massive drug price cuts
• by Kim, Jin-Gu Sep 6, 2023 05:36am

• Opinion
• [Desk’s View] Compensate for the value of novel drugs
• by Lee, Tak-Sun Sep 6, 2023 05:36am

• Opinion
• [Reporter’s View] Disclose PVA results in advance as well
• by Lee, Tak-Sun Sep 4, 2023 05:04am